| Financial Year |
March 31 2023 |
| Monetary Funds |
2,028,105,482.24 |
| Held-for-trading Financial Assets |
601,821,146.00 |
| Notes Receivable |
12,145,745.97 |
| Accounts Receivable |
621,310,080.06 |
| Advances to Suppliers |
15,496,006.81 |
| Other Receivables |
17,092,865.70 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
791,309,281.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,022,819.69 |
| Total Current Assets |
4,376,079,986.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
115,322,838.23 |
| Investment Properties |
147,105,079.99 |
| Fixed Assetes |
1,549,991,571.92 |
| Under-construction Projects |
43,331,984.23 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
141,627,403.69 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
38,198,600.73 |
| Other Non-Current Assets |
951,727.25 |
| Sub-Total of Non-Current Assets |
2,094,692,535.74 |
| Total Assets |
6,470,772,522.13 |
| Short-Term Loans |
654,543,184.71 |
| Trading Financial liabilities |
-- |
| Notes Payable |
853,766,135.04 |
| Accounts Payable |
945,972,291.66 |
| Accounts Received In Advance |
17,296,531.30 |
| Employee Compensation Payable |
47,006,086.39 |
| Taxes Payable |
17,611,403.91 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,575,824.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
984,691,905.13 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
3,540,994,062.69 |
| Long-term Loans |
50,068,750.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
181,484,449.62 |
| Total Liabilities |
3,722,478,512.31 |
| Paid-In Capital(Or Share Stock) |
737,688,949.00 |
| Capital Surplus |
1,137,849,951.91 |
| Surplus Reserve |
149,388,075.08 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
561,785,960.48 |
| Minority Stockholder's Interest |
40,836,275.45 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,707,457,734.37 |
| Owner's Equity（Stockholder's Equity） |
2,748,294,009.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,470,772,522.13 |
